Companies that own Novavax Inc.
BlackRock Fund Advisors
28,101,536
7.35%
4,541,281
0%
06/30/2018
SSgA Funds Management, Inc.
23,307,696
6.09%
-1,923,889
0%
06/30/2018
The Vanguard Group, Inc.
20,530,223
5.37%
4,880,360
0%
06/30/2018
Bellevue Asset Management AG
8,330,000
2.18%
0
0.19%
06/30/2018
Morgan Stanley & Co. LLC
6,187,488
1.62%
3,596,157
0.01%
06/30/2018
Franklin Advisers, Inc.
5,711,765
1.49%
0
0.01%
06/30/2018
Northern Trust Investments, Inc.
4,452,853
1.15%
820,846
0%
06/30/2018
Fidelity Management & Research Co.
4,359,642
1.13%
0
0%
06/30/2018
Geode Capital Management LLC
3,953,866
1.03%
933,976
0%
06/30/2018
Heights Capital Management, Inc.
3,315,597
0.87%
3,315,597
0.15%
06/30/2018
| Address |
20 Firstfield Road
Gaithersburg Maryland 20878
United States
|
|
Employees
|
- |
| Website |
http://www.novavax.com |
| Updated |
09/14/2018 |
| Novavax, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the provision of development of recombinant nanoparticle vaccines and adjuvants. Its product pipeline targets infectious diseases with vaccine candidates in clinical development for respiratory syncytial virus, seasonal influenza, pandemic influenza, and Ebola virus. The company was founded in 1987 and is headquartered in Gaithersburg, MD. |
